{"transactions":[{"id":748730,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-05T20:25:00.000Z","date":"2026-06-04","kind":"grant","planned":false,"acquired":true,"shares":59701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":152030,"source":{"system":"sec-edgar","filing":"0001740730-26-000002","document":"wk-form4_1780691097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000174073026000002/wk-form4_1780691097.xml","form_type":"4"}},{"id":766441,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true}}],"security":"Stock Option  (Right to Buy)","published_at":"2026-05-22T20:16:41.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":1441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":1441,"derivative":{"exercise_price":298.48,"exercise_date":"2027-05-20","expiration_date":"2036-05-20","underlying":"Common Stock","underlying_shares":1441},"source":{"system":"sec-edgar","filing":"0001178670-26-000040","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000117867026000040/form4.xml","form_type":"4"}},{"id":766440,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-22T20:16:41.000Z","date":"2026-05-20","kind":"grant","planned":false,"acquired":true,"shares":671,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (RSUs) granted under the Second Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":1446,"source":{"system":"sec-edgar","filing":"0001178670-26-000040","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000117867026000040/form4.xml","form_type":"4"}},{"id":1043102,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"exercise","planned":true,"acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"This stock option was fully vested and exercisable as of June 1, 2021."}],"balance_after":0,"derivative":{"exercise_price":100.65,"expiration_date":"2028-06-01","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043101,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":25,"price":480.98,"value":12024.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."}],"balance_after":775,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043100,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":1386,"price":479.55,"value":664656.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F16","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $479.35 to $479.90. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":800,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043099,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":1450,"price":478.67,"value":694071.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F15","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $478.33 to $479.30. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":2186,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043098,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":1183,"price":477.47,"value":564847.01,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $477.05 to $477.88. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":3636,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043097,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":972,"price":476.31,"value":462973.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $475.85 to $476.79. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":4819,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043096,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":951,"price":474.85,"value":451582.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $474.58 to $475.06. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":5791,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043095,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":838,"price":474.22,"value":397396.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $473.48 to $474.48. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":6742,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043094,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":823,"price":472.82,"value":389130.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $472.37 to $473.30. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":7580,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043093,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":222,"price":471.25,"value":104617.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $470.77 to $471.75. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":8403,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043092,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":799,"price":464.36,"value":371023.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $464.18 to $464.96. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":8625,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043091,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":1652,"price":463,"value":764876.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $462.73 to $463.52. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":9424,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043090,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":2290,"price":461.92,"value":1057796.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $461.42 to $462.41. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":11076,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043089,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":473,"price":460.71,"value":217915.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $460.35 to $461.26. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":13366,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043088,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":1403,"price":459.73,"value":645001.19,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $459.29 to $460.22. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":13839,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043087,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":1888,"price":458.86,"value":866327.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $458.22 to $459.09. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":15242,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043086,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"sale","planned":true,"acquired":false,"shares":1645,"price":457.44,"value":752488.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $456.93 to $457.91. The reporting person will provide to the issuer, any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range."}],"balance_after":17130,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1043085,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-09-11T20:05:55.000Z","date":"2025-09-09","kind":"exercise","planned":true,"acquired":true,"shares":18000,"price":100.65,"value":1811700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on June 10, 2025."}],"balance_after":18775,"source":{"system":"sec-edgar","filing":"0001735276-25-000097","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000097/edgardoc.xml","form_type":"4"}},{"id":1120390,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-06T20:04:42.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":49796,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan, as amended. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant or (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":92329,"source":{"system":"sec-edgar","filing":"0001628280-25-029973","document":"wk-form4_1749240274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025029973/wk-form4_1749240274.xml","form_type":"4"}},{"id":1152508,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2025-05-12T20:05:00.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":1558,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":1558,"derivative":{"exercise_price":258.35,"exercise_date":"2026-05-08","expiration_date":"2035-05-08","underlying":"Common Stock","underlying_shares":1558},"source":{"system":"sec-edgar","filing":"0001735276-25-000062","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000062/edgardoc.xml","form_type":"4"}},{"id":1152507,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T20:05:00.000Z","date":"2025-05-08","kind":"grant","planned":false,"acquired":true,"shares":775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are represented by restricted stock units (RSUs) granted under the Amended and Restated 2018 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. The RSUs will vest in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":775,"source":{"system":"sec-edgar","filing":"0001735276-25-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000062/edgardoc.xml","form_type":"4"}},{"id":1152506,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T20:05:00.000Z","date":"2025-04-16","kind":"sale","planned":false,"acquired":false,"shares":36,"price":232.86,"value":8382.96,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001735276-25-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000062/edgardoc.xml","form_type":"4"}},{"id":1152505,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T20:05:00.000Z","date":"2024-10-17","kind":"purchase","planned":false,"acquired":true,"shares":4,"price":302.67,"value":1210.68,"ownership":{"direct":true},"balance_after":36,"source":{"system":"sec-edgar","filing":"0001735276-25-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000062/edgardoc.xml","form_type":"4"}},{"id":1152504,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-12T20:05:00.000Z","date":"2024-08-29","kind":"purchase","planned":false,"acquired":true,"shares":32,"price":286,"value":9152.0,"ownership":{"direct":true},"balance_after":32,"source":{"system":"sec-edgar","filing":"0001735276-25-000062","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527625000062/edgardoc.xml","form_type":"4"}},{"id":1416749,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-09-04T23:38:06.000Z","date":"2024-09-03","kind":"sale","planned":true,"acquired":false,"shares":46012,"price":27.946,"value":1285851.352,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.45 to $28.47, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":42533,"source":{"system":"sec-edgar","filing":"0001628280-24-039405","document":"wk-form4_1725487777.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024039405/wk-form4_1725487777.xml","form_type":"4"}},{"id":1487589,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T20:54:04.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":15695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":88545,"source":{"system":"sec-edgar","filing":"0001628280-24-027331","document":"wk-form4_1717793637.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024027331/wk-form4_1717793637.xml","form_type":"4"}},{"id":1509303,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2024-05-20T20:06:00.000Z","date":"2024-05-16","kind":"grant","planned":false,"acquired":true,"shares":5228,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":5228,"derivative":{"exercise_price":151.22,"exercise_date":"2025-05-16","expiration_date":"2034-05-16","underlying":"Common Stock","underlying_shares":5228},"source":{"system":"sec-edgar","filing":"0001735276-24-000049","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527624000049/edgardoc.xml","form_type":"4"}},{"id":1870916,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T22:11:25.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":15151,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":72850,"source":{"system":"sec-edgar","filing":"0001628280-23-020711","document":"wk-form4_1685743873.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023020711/wk-form4_1685743873.xml","form_type":"4"}},{"id":1885134,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2023-05-19T20:05:45.000Z","date":"2023-05-18","kind":"grant","planned":false,"acquired":true,"shares":3454,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":3454,"derivative":{"exercise_price":189.87,"exercise_date":"2024-05-18","expiration_date":"2033-05-18","underlying":"Common Stock","underlying_shares":3454},"source":{"system":"sec-edgar","filing":"0001735276-23-000064","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527623000064/edgardoc.xml","form_type":"4"}},{"id":2246007,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T21:25:59.000Z","date":"2022-06-02","kind":"grant","acquired":true,"shares":17275,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the Date of Grant and (b) the date of the next annual meeting of stockholders following such grant."}],"balance_after":57699,"source":{"system":"sec-edgar","filing":"0001628280-22-016217","document":"wf-form4_165429154410113.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022016217/wf-form4_165429154410113.xml","form_type":"4"}},{"id":2262172,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2022-05-20T20:07:16.000Z","date":"2022-05-18","kind":"grant","acquired":true,"shares":5153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":5153,"derivative":{"exercise_price":128.31,"exercise_date":"2023-05-18","expiration_date":"2032-05-17","underlying":"Common Stock","underlying_shares":5153},"source":{"system":"sec-edgar","filing":"0001735276-22-000052","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527622000052/edgardoc.xml","form_type":"4"}},{"id":2630797,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2021-07-19T20:22:02.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":4032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in full upon the earlier of the first anniversary of the grant date and the date of any earlier retirement or resignation of the Reporting Person, provided such date of retirement or resignation occurs no more than 90 days prior to the first anniversary of the grant date."}],"balance_after":4032,"derivative":{"exercise_price":171.95,"exercise_date":"2022-07-15","expiration_date":"2031-07-14","underlying":"Common Stock","underlying_shares":4032},"source":{"system":"sec-edgar","filing":"0001735276-21-000070","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527621000070/edgardoc.xml","form_type":"4"}},{"id":2681734,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-04T23:43:36.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":12848,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests on the anniversary of the date of grant."}],"balance_after":40424,"source":{"system":"sec-edgar","filing":"0000899243-21-022153","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000089924321022153/doc4.xml","form_type":"4"}},{"id":2955665,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-12-07T23:44:08.000Z","date":"2020-12-04","kind":"grant","acquired":true,"shares":15889,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant."}],"balance_after":27576,"source":{"system":"sec-edgar","filing":"0000899243-20-032908","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000089924320032908/doc4.xml","form_type":"4"}},{"id":3089161,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2020-07-06T20:50:30.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":4581,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4581,"derivative":{"exercise_price":148.77,"exercise_date":"2021-07-01","expiration_date":"2030-07-01","underlying":"Common Stock","underlying_shares":4581},"source":{"system":"sec-edgar","filing":"0001735276-20-000075","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527620000075/edgardoc.xml","form_type":"4"}},{"id":3350247,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-12-06T20:25:25.000Z","date":"2019-12-05","kind":"grant","acquired":true,"shares":11687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests on the anniversary of the date of grant."}],"balance_after":11687,"source":{"system":"sec-edgar","filing":"0000899243-19-028658","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000089924319028658/doc4.xml","form_type":"4"}},{"id":3471567,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2019-07-02T20:06:27.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9000,"derivative":{"exercise_price":72.01,"exercise_date":"2020-07-01","expiration_date":"2029-06-30","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0001735276-19-000064","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527619000064/edgardoc.xml","form_type":"4"}},{"id":3908647,"issuer":{"id":3132,"kind":"organization","name":"ALNYLAM PHARMACEUTICALS, INC.","symbol":"ALNY"},"owners":[{"id":41112,"kind":"person","name":"Reitan Colleen F","position":1,"cik":"0001740730","reported_name":"Reitan Colleen F","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2018-06-04T20:44:50.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option will vest as to one third of the shares on each of the first, second and third anniversaries of the date of grant."}],"balance_after":18000,"derivative":{"exercise_price":100.65,"expiration_date":"2028-06-01","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001735276-18-000011","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1178670/000173527618000011/edgardoc.xml","form_type":"4"}}]}